SOPHiA GENETICS SA SOPH
At closeNov 3, 2026, 5:56 PM EST
After hours · Nov 3, 5:56 PM ET
- YTD
- +47.97%
- 1 year
- +38.20%
- Market cap
- 588.23M
- Revenue (ttm)
- 64.49M
- Profit margin
- -110.71%
- EPS (ttm)
- -1.16
- Shares out
- 66.44M
- Forward P/E
- -4.09
- YTD return
- +47.97%
- 1-year return
- +38.20%
- Volume
- 2.31M
- Avg volume
- 606.79K
- Open
- 6.50
- Previous close
- 7.11
- Day's range
- 5.92 – 7.19
- 52-week range
- 3.83 – 8.98
- Beta
- 1.03
- Analysts
- Strong Buy
- Price target
- 7.00 (+1.3%)
- Earnings date
- Aug 6, 2024
2Y +3.15 (+84.00%)
Key statistics
- Enterprise value
- 152.48M
- PEG ratio
- 0.00
- Price / sales
- 3.41
- Price / book
- 1.94
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -2.80%
- Free cash flow
- -26.18M
- Total cash
- 95.79M
- Total debt
- 31.67M
- Return on equity
- -52.51%
- Short % of float
- 0.05%
- 50-day average
- 3.43
- 200-day average
- 4.18
Analyst view
Consensus: strong buy
- Target (low)
- 5.00
- Target (mean)
- 7.00
- Target (high)
- 11.00
- Strong buy1
- Buy4
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 6, 2024
Expected Aug 6, 2024. Consensus EPS estimate -0.15.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2024 | Sep 1, 2024 | -0.24 | -0.28 | -0.04 | -16.67% |
| Aug 6, 2024 | Jun 1, 2024 | -0.28 | -0.23 | +0.05 | +17.86% |
| Aug 6, 2024 | Jun 1, 2024 | -0.28 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | -0.25 | -0.21 | +0.04 | +16.00% |
| May 7, 2024 | Mar 1, 2024 | -0.25 | — | — | — |
| Mar 5, 2024 | Dec 1, 2023 | -0.25 | -0.37 | -0.12 | -48.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Craig-Hallum | init | — | Buy |
| Aug 7, 2024 | RBC Capital | main | Outperform | Outperform |
| Jun 27, 2024 | Guggenheim | init | — | Buy |
| Mar 6, 2024 | BTIG | main | Buy | Buy |
| Mar 6, 2024 | RBC Capital | reit | Outperform | Outperform |
| Jan 12, 2024 | RBC Capital | reit | Outperform | Outperform |
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- Switzerland
- Website
- sophiagenetics.com
News
SOPHiA GENETICS SA (SOPH) Q3 2026 Earnings Call Transcript 
SOPHiA GENETICS Q3 Earnings Call Highlights 
Sophia Genetics Q3 2026 Earnings Call Transcript 
SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Beats Revenue Estimates 
Sophia Genetics Raises FY2026 Sales Guidance from $94.000M-$96.000M to $96.000M vs $95.252M Est 
Sophia Genetics Q3 EPS $(0.24) Misses $(0.18) Estimate, Sales $24.267M Beat $24.035M Estimate 
SOPHiA GENETICS Reports Third Quarter 2026 Results 
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026 
HC Wainwright & Co. Reiterates Buy on Sophia Genetics, Maintains $14 Price Target 
SOPHiA GENETICS, Myriad Genetics Collaborate To Advance New Prostate Cancer-specific Genomic Instability Score Technology
Your note
Sign in to keep a note on SOPH — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Generation Investment Management LLP | 10.39% | 6,789,560 | 22.47M | Sep 29, 2024 |
| Banque Pictet & Cie SA | 3.43% | 2,243,240 | 7.43M | Sep 29, 2024 |
| Akre Capital Management, LLC | 3.42% | 2,237,504 | 7.41M | Sep 29, 2024 |
| UBS Asset Management Americas Inc | 3.40% | 2,220,322 | 7.35M | Sep 29, 2024 |
| Principal Financial Group, Inc. | 2.23% | 1,455,142 | 4.82M | Sep 29, 2024 |
| Alta Wealth Advisors LLC | 2.16% | 1,409,160 | 4.66M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Principal Small Cap Fund | 0.73% | 476,200 | 1.58M | Jul 30, 2024 |
| 1290 Fds-1290 Essex Small Cap Growth Fd | 0.09% | 56,119 | 185.75K | Jul 30, 2024 |
| Principal Var Contracts Fund-SmallCap Account | 0.08% | 52,700 | 174.44K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index ETF | 0.07% | 48,902 | 161.87K | Oct 30, 2024 |
| Federated Hermes Prudent Bear Fund | 0.06% | 37,406 | 123.81K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 40,573 | 134.30K | Oct 30, 2024 |